Well Told Grants

Federal grant recipients / Massachusetts

Federal grants to Dynocardia, Inc

Cambridge, Massachusetts · Small businesses · UEI HMN7FWLXJ1H4

Dynocardia, Inc in Cambridge, Massachusetts received $6.3 million in federal grants from fiscal 2021 to 2025, across 7 awards. Its largest program was Cardiovascular Diseases Research, with $4.7 million. It had no new grant money in fiscal 2025.

From USAspending.gov award records, updated October 31, 2026.

By year

Federal grants to Dynocardia, Inc by fiscal year
Fiscal yearAwardsAmount
FY 20212$973,855
FY 20223$1.4 million
FY 20231$1.3 million
FY 20243$2.7 million
FY 20250$0

An award funded in several years counts in each of them, so yearly awards add up to more than the five-year total.

Programs that fund Dynocardia, Inc

Every program, fiscal 2021 to 2025
ProgramAwardsAmount
Cardiovascular Diseases Research 93.8373$4.7 million
Technology, Innovation, and Partnerships 47.0841$999,553
Engineering 47.0411$256,000
Discovery and Applied Research for Technological Innovations to Improve Human Health 93.2861$250,001
Aging Research 93.8661$153,969

Awarding agencies

AgencyAwardsAmount
Department of Health and Human Services5$5.1 million
National Science Foundation2$1.3 million

Largest awards

The 7 largest awards by money obligated in fiscal 2021 to 2025
AwardProgramFirst actionAmount
Vitrack: wearable, accurate, continuous blood pressure monitor to improve outcomes in hypertensive diseases of pregnancy - dynocardia, a tufts university school of medicine and Massachusetts institute of technology spinoff, is addressing an unmet need for real-world accurate and continuous non-invas
ASST_NON_R44HL167356_075 on USAspending
Cardiovascular Diseases ResearchJanuary 3, 2023$2.4 million
Continuous non-invasive assessment of blood pressure profile in persons with alzheimer's and its related dementias - project summary there is an unmet clinical need for an accurate, standalone, continuous non-invasive blood pressure (CNIBP) monitor. Current non-invasive, occlusive arm cuff-based bp
ASST_NON_R44HL158374_075 on USAspending
Cardiovascular Diseases ResearchJune 11, 2021$1.7 million
Sbir phase II: development of motion artifact correction systems for vitrack: an accurate, continuous, and non-invasive blood pressure monitor -the broader impact/commercial potential of this small business innovation research (SBIR) phase II project is to meet the urgent need for a wearable blood p
ASST_NON_2423296_049 on USAspending
Technology, Innovation, and PartnershipsAugust 30, 2024$999,553
Design verification and validation of vitrack - an accurate, continuous, non-invasive blood pressure monitor - project summary current non-invasive blood pressure (BP) technologies are occlusive arm cuff-based and provide only single- point bp measurements. In us hospitals, 35 million critically ill
ASST_NON_SB1HL176287_075 on USAspending
Cardiovascular Diseases ResearchAugust 30, 2024$499,881
Sbir phase i: motion artifact management for accurate and continuous non-invasive blood pressure monitoring -the broader impact/commercial potential of this small business innovation research (SBIR) phase i project is to enable accurate, continuous, and widely available blood pressure (BP) measureme
ASST_NON_2151591_049 on USAspending
EngineeringFebruary 18, 2022$256,000
Continuous non-invasive assessment of blood pressure profile in persons with alzheimer's and its related dementias - project summary there is an unmet clinical need for an accurate, standalone, continuous non-invasive blood pressure (CNIBP) monitor. Current non-invasive, occlusive arm cuff-based bp
ASST_NON_R44HL158374_075 on USAspending
Discovery and Applied Research for Technological Innovations to Improve Human HealthJune 11, 2021$250,001
Continuous non-invasive assessment of blood pressure profile in persons with alzheimer's and its related dementias - project summary there is an unmet clinical need for an accurate, standalone, continuous non-invasive blood pressure (CNIBP) monitor. Current non-invasive, occlusive arm cuff-based bp
ASST_NON_R44HL158374_075 on USAspending
Aging ResearchJune 11, 2022$153,969

Amounts are net obligations: money committed, minus any amounts taken back. They are not payments. See how our data works.

Questions people ask

How much federal grant money does Dynocardia, Inc get?

$6.3 million in 7 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.

Which agency gives Dynocardia, Inc the most?

The Department of Health and Human Services, with $5.1 million in 5 awards. The National Science Foundation follow.

What is Dynocardia, Inc's largest federal grant?

$2.4 million under Cardiovascular Diseases Research, with its first action in the period on January 3, 2023. That counts only the money obligated in fiscal 2021 to 2025.

Which federal programs fund Dynocardia, Inc?

Its largest are Cardiovascular Diseases Research, Technology, Innovation, and Partnerships and Engineering.

Other grant recipients in Cambridge

Largest federal grant recipients in Massachusetts · Federal grants in Massachusetts